Laurus Center for Gene Therapy

Laurus Center for Gene Therapy (LCGT) is a specialized contract development and manufacturing organization (CDMO) focused on the production of viral vectors and plasmid DNA. As a division of Laurus Bio, the center provides end-to-end services including process development, analytical development, and large-scale GMP manufacturing. LCGT specifically targets the global cell and gene therapy market, offering expertise in Adeno-associated virus (AAV) and Lentivirus production using advanced single-use technologies. The facility is designed to comply with global regulatory standards, supporting biopharmaceutical partners from early-stage research through commercial supply. By leveraging the infrastructure of its parent company, Laurus Labs, LCGT aims to provide cost-effective and scalable solutions for complex genetic medicines.